RAC1 and chronic myelogenous leukemia, BCR-ABL1 positive: The increases in glomerular CML, RAGE, MR, and Rac1 expressions as well as plasma CML and cortical RAGE levels in DOCA-Ctrl-apt–treated mice were also significantly reduced by RAGE-apt or spironolactone (Spiro) (Fig. 4f–k).